news
22.12.05
GBL complete funding round
GBL has just completed its first funding round of £63k drawn primarily from investors in the local based business angel community. The funding together with profit from service contracts and grant funding will be used to develop and test the advanced compost accelerant product at scale.
Dr Edward Green, CEO of GBL comments “I am delighted to complete our first round. Equity investment is an important milestone for company development and rounds off a very successful year. We have moved to Milton Park with improved facilities, the technology platform has been strengthened and the Company is much better resourced for acceleration of in house product development and commercialisation. I am extremely grateful for all the support we have received and excited about the prospects for 2006”
16.11.05
CEO wins award
Dr Edward Green CEO of Green Biologics (left) recieves his award in the category of ‘up and coming entrepreneur’ at the inaugural Martin and Audrey Wood Enterprise Awards 2005 from Iain Laing.
“Over 150 representatives from the business, technology, research and investment communities in Oxfordshire and beyond gathered at Culham Science Centre on the 9th of November as the winners of the Martin and Audrey Wood Enterprise Awards 2005 were chosen. It was the inaugural year for the Awards, which focus on innovative and technology-based companies and promising entrepreneurs, and were established in honour of Sir Martin and Lady (Audrey) Wood, co-founders of Oxford Instruments plc.
The Winner of the Up and Coming Entrepreneur Award was: Dr Edward Green, Chief Executive Officer of Green Biologics Ltd, which has developed a technology to exploit the properties of heat-loving micro-organisms (called thermophiles) that can be used to accelerate composting times for biodegradable waste. The company is also developing a novel solvent system to remove chewing gum waste from pavements. Dr Green received his Award from Ian Laing, co-founder of Milton Park and High Sheriff of Oxfordshire.”
Read more in the press release.
24.10.05
CEO in entrepreneurial final
Green Biologics founder and CEO Dr Edward Green has been listed as a finalist for the ‘up and coming entrepreneur’ catagory of the Martin and Audrey Wood Enterprise Awards. An annual award ceremony celebrating innovators, entrepreneurs and young technology companies.
21.10.05
GBL wins green shoot recognition
Green Biologics have been placed as runners up in a locally managed competition promoted in partnership with Milton Park and Oxford Brookes University. The Green Shoots award was launched earlier this summer (2005) for environmentally focused new and start-up companies to win free business accommodation and mentoring worth over £15,000.
Entrants had to have a business plan or be a company with a strong environmental connection. The award attracted considerable interest from a wide range of individuals and companies in the Oxfordshire area.
26.09.05
GBL moves to new premises
GBL moved from the Oxford BioBusiness to Unit 45A Milton Park, Abingdon on the
03.06.05
Website update
GBL launches the updated website (www.greenbiologics.com) designed by Cranleigh-based web design company Kyanmedia. The website reflects the considerable progress that GBL has made over the last eighteen months with regard to technical, commercial and corporate development.
The new website uses advanced CSS layout techniques to maintain code hierarchy and an in built content management system for rapid and convenient updates.
01.03.05
GBL appoints chief financial officer
GBL appoints Simon Jones as CFO. Simon is a qualified Chartered Accountant. He first spent time with Ernst and Young and then held a number of senior posts with Unipart. He joined Oxonica in 2000 as CFO and was involved with several fund raising rounds, commercial development of the company including negotiating IP in-licensing and out-licensing agreements and the first major sales contract for the lead product.
Simon has considerable financial and commercial experience from work with early stage companies. He will be a considerable asset to GBL as the company seeks to commercialise its first product.
archive
View latest stories
View news stories from 2005
View news stories from 2004
View news stories from 2003
Top — © All content Green Biologics 2004 — Terms
and Conditions — Privacy
Policy
